JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1981) 88, 181-186    DOI: 10.1677/joe.0.0880181
© 1981 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LÁSZLÓ, F. A.
Right arrow Articles by MORGAT, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LÁSZLÓ, F. A.
Right arrow Articles by MORGAT, J.-L.

BIOLOGICAL HALF-LIFE AND ORGAN DISTRIBUTION OF [3H]1-DEAMINO-8-D-ARGININE-VASOPRESSIN IN THE RAT

F. A. LÁSZLÓ, T. JANÁKY, L. BALÁSPIRI and J.-L. MORGAT

The biological half-life of synthetic, radiochemically pure, biologically active [3H]1-deamino-8-D-arginine-vasopressin (dDAVP) in rats was found to be 5·33 ± 0·28 (S.E.M.) min in the initial, transitional, fast phase and 56·28 ± 3·27 min in the second, slow phase. The substance accumulated to the greatest extent in the kidney and small intestine and only slightly in the adenohypophysis. The results have suggested that the extended biological half-life may play a role in the more marked and longer antidiuretic effect of dDAVP. The explanation of the poor accumulation in the adenohypophysis may be that dDAVP does not possess an effect similar to that of corticotrophin releasing factor.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the Society for Endocrinology.